Antitumor antibiotic; semi-synthetic derivative of nogalamycin. Prepn: P. F. Wiley, D. J. Houser, US 4086245 (1978 to Upjohn). Total synthesis: M. Kawasaki et al., Tetrahedron 44, 5727 (1988). Antitumor activity: G. L. Neil et al., Cancer Treat. Rep. 63, 1971 (1979). HPLC determn in plasma: J. E. Brown et al., J. Chromatogr. 226, 521 (1981); J. P. McGovren et al., Anal. Chem. 56, 1587 (1984). Pharmacokinetics and metabolism: M. J. Egorin et al., Cancer Res. 46, 1513 (1986). Mechanism of action: K. Wierzba et al., Jpn. J. Cancer Res. 81, 842 (1990). Clinical studies in non-small cell lung cancer: R. B. Vance et al., Invest. New Drugs 9, 73 (1991); in non-Hodgkin's lymphoma: J. Skillings et al., ibid., 79. Brief review of antitumor, biochemical, and toxicological studies: J. P. McGovren et al., ibid. 2, 359-367 (1984).
This monograph has been retired and is no longer subject to revision or update.